News Tag: COVID-19
-
Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research
Clinical trials are assessing whether the drug can temper the immune system’s response to coronavirus in the lungs, preventing the dangerous inflammation seen in patients with severe disease.
-
Scripps Research expands international effort to rapidly repurpose existing drugs against COVID-19
An international research network centers around ReFRAME, the world’s leading collection of drugs known to be safe in humans.
-
Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS
An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the coronavirus at the root of COVID-19.
-
New website aggregates global COVID-19 research to boost data usability for all
Developed collaboratively by several Scripps Research teams, Outbreak.info seeks to bring together research information on a single site and improve data visualization.
-
Your computer can help scientists seek potential COVID-19 treatments
IBM's World Community Grid hosts Scripps Research project to virtually screen chemical compounds that might help fight COVID-19.
-
COVID-19 survivors needed for Scripps Research antibody study
Antibodies that are circulating in the blood of patients who’ve recovered from COVID-19 may serve as the key to developing an effective vaccine against the virus.
-
Scripps Research invites public to join app-based DETECT study, leveraging wearable data to potentially flag onset of viral illnesses
The study seeks to evaluate shared data from wearable users as part of a program to improve detection and containment of infectious disease outbreaks.
-
Scripps Research scientists tackle COVID-19 coronavirus pandemic from many angles
Ongoing studies reveal important information about how the virus spreads and infects the body, and point to different approaches for potential vaccines and medicines.
-
Scripps Research scientists leveraging ReFRAME drug repurposing collection against COVID-19 coronavirus epidemic
Calibr scientists work to repurpose existing drugs against novel coronavirus.
-
The COVID-19 coronavirus epidemic has a natural origin, scientists say
By analyzing public genome sequence data from the virus that causes COVID-19, the research team found no evidence that the pathogen was made in a laboratory or otherwise engineered.